|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's range||20.76 - 20.76|
|52-week range||20.76 - 20.76|
|Beta (5Y monthly)||0.55|
|PE ratio (TTM)||24.42|
|Earnings date||03 May 2023 - 08 May 2023|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Here are 5 biggest share buyback announcements from the past week you may have missed on InvestingPro. Verisk Analytics (NASDAQ:VRSK) announced that it has entered into accelerated share repurchase agreements with each of Citibank, and Goldman Sachs to repurchase an aggregate of $2.5B of the company's common stock. Morgan Stanley said on Thursday it's adding a position to the company, given (1) industry-standard network effects in an attractive industry, (2) attractive valuation after the company’s return to its traditional property and casualty-focused end markets after selling non-core business segments, and (3) from a portfolio perspective, reduces the Model’s volatility and exposure to consumer discretionary while adding exposure to high-quality industrials.
Corcept Therapeutics ( NASDAQ:CORT ) Full Year 2022 Results Key Financial Results Revenue: US$401.9m (up 9.8% from FY...
Corcept Therapeutics' (CORT) fourth-quarter earnings and revenues lag estimates.